Nothing Special   »   [go: up one dir, main page]

FR2187327B1 - - Google Patents

Info

Publication number
FR2187327B1
FR2187327B1 FR7221607A FR7221607A FR2187327B1 FR 2187327 B1 FR2187327 B1 FR 2187327B1 FR 7221607 A FR7221607 A FR 7221607A FR 7221607 A FR7221607 A FR 7221607A FR 2187327 B1 FR2187327 B1 FR 2187327B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7221607A
Other versions
FR2187327A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RECH PHARM SCIENTIFIQUES
Original Assignee
RECH PHARM SCIENTIFIQUES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RECH PHARM SCIENTIFIQUES filed Critical RECH PHARM SCIENTIFIQUES
Priority to FR7221607A priority Critical patent/FR2187327B1/fr
Priority to ES415277A priority patent/ES415277A1/es
Priority to CA173,160A priority patent/CA1019745A/fr
Priority to ZA733812A priority patent/ZA733812B/xx
Priority to US05/367,821 priority patent/US3950387A/en
Priority to GB2729173A priority patent/GB1389814A/en
Priority to JP48066246A priority patent/JPS5239815B2/ja
Priority to DE19732329819 priority patent/DE2329819C3/de
Priority to AU56772/73A priority patent/AU490997B2/en
Publication of FR2187327A1 publication Critical patent/FR2187327A1/fr
Application granted granted Critical
Publication of FR2187327B1 publication Critical patent/FR2187327B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
FR7221607A 1972-06-15 1972-06-15 Expired FR2187327B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR7221607A FR2187327B1 (fr) 1972-06-15 1972-06-15
ES415277A ES415277A1 (es) 1972-06-15 1973-05-28 Procedimiento de preparacion de derivados de la cisterna.
CA173,160A CA1019745A (fr) 1972-06-15 1973-06-04 Mode de preparation des derives de la cysteine
ZA733812A ZA733812B (en) 1972-06-15 1973-06-05 Cysteine derivatives
US05/367,821 US3950387A (en) 1972-06-15 1973-06-07 Cysteine derivatives
GB2729173A GB1389814A (en) 1972-06-15 1973-06-07 Cysteine derivatives and production thereof
JP48066246A JPS5239815B2 (fr) 1972-06-15 1973-06-11
DE19732329819 DE2329819C3 (de) 1972-06-15 1973-06-12 S-Substituierte-L-Cysteine und Verfahren zu ihrer Herstellung
AU56772/73A AU490997B2 (en) 1972-06-15 1973-06-12 Cysteine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7221607A FR2187327B1 (fr) 1972-06-15 1972-06-15

Publications (2)

Publication Number Publication Date
FR2187327A1 FR2187327A1 (fr) 1974-01-18
FR2187327B1 true FR2187327B1 (fr) 1975-06-20

Family

ID=9100257

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7221607A Expired FR2187327B1 (fr) 1972-06-15 1972-06-15

Country Status (7)

Country Link
US (1) US3950387A (fr)
JP (1) JPS5239815B2 (fr)
CA (1) CA1019745A (fr)
ES (1) ES415277A1 (fr)
FR (1) FR2187327B1 (fr)
GB (1) GB1389814A (fr)
ZA (1) ZA733812B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002634A (en) * 1969-09-04 1977-01-11 Societe Anonyme Dite: L'oreal N-oxypyridyl substituted cysteine or cysteine derivative thereof
US4105789A (en) * 1976-05-10 1978-08-08 E. R. Squibb & Sons, Inc. Carboxyalkylacylamino acids
US4160835A (en) * 1976-11-19 1979-07-10 Merck & Co., Inc. Antihypertensive compositions containing an arylsubstituted alanine and a phenyl hydrazinopropionic acid
US4093739A (en) * 1977-06-15 1978-06-06 Mead Johnson & Company Mercaptoacylamidobenzoyl glycine and mucolytic process
ES469060A1 (es) * 1978-04-22 1979-04-01 Invest Tecnica Aplicada Procedimiento para la preparacion de nuevos derivados tio- prenilicos con actividad farmacologica
LU83327A1 (fr) * 1981-04-29 1983-03-24 Midit Procede de preparation de derives de 1,4-thiazine,leur utilisation ainsi que compositions contenant ces derives
US4571430A (en) * 1982-11-08 1986-02-18 Medi-Physics, Inc. Homocysteine and homocysteinamide derivatives
US6030950A (en) * 1987-07-09 2000-02-29 Ohlenschlaeger; Gerhard Pharmaceutical therapeutic use of glutathione derivative
GB2217706A (en) * 1988-07-07 1989-11-01 W A Gibbons alpha -Amino-alkanoic acid derivatives and process for their preparation with anti-inflammatory, analgesic, sedative, hypnotic, anxiolytic, spasmolytic, anaesthetic, muscle relaxant and cardiovascular activity
US5464825A (en) * 1991-03-14 1995-11-07 Cornell Research Foundation, Inc. Raising glutathione equivalent levels using N-acyl glutathione monoesters
CA2099346A1 (fr) * 1992-07-17 1994-01-18 Shinji Ohmori Composition ameliorant le metabolisme de lipides
WO1994025052A1 (fr) * 1993-05-03 1994-11-10 Cornell Research Foundation, Inc. Utilisation de diesters de glutathione
JP4255138B2 (ja) * 1996-05-24 2009-04-15 湧永製薬株式会社 脳疾患治療剤
US6492429B1 (en) * 2000-07-10 2002-12-10 N.V. Nutricia Composition for the treatment of osteoarthritis
US6384078B1 (en) * 2000-11-21 2002-05-07 Arthur Vanmoor Method of treating elevated cholesterol levels by enhancing the effectiveness of the human immune system
US8765817B1 (en) 2008-12-03 2014-07-01 Arrowhead Center, Inc. Selective inhibitors of EG5 motors and methods of use
US8349899B1 (en) 2008-12-03 2013-01-08 Arrowhead Center, Inc. Selective inhibitors of EG5 motors and methods of use
JP2013035772A (ja) * 2011-08-05 2013-02-21 Osaka City Univ 白血球活性化抑制剤
KR101511056B1 (ko) * 2013-06-28 2015-04-10 한밭대학교 산학협력단 신규한 ｓ-알릴 시스테인 유도체 및 그의 용도
WO2017096450A1 (fr) * 2015-12-07 2017-06-15 Ems S/A Nouveaux composés ayant une activité antioxydante et anti-âge

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3531490A (en) * 1968-09-06 1970-09-29 Us Agriculture S-beta-(4-pyridylethyl)-l-cysteine

Also Published As

Publication number Publication date
JPS504020A (fr) 1975-01-16
GB1389814A (en) 1975-04-09
DE2329819B2 (de) 1977-04-07
US3950387A (en) 1976-04-13
ZA733812B (en) 1974-04-24
DE2329819A1 (de) 1974-01-03
FR2187327A1 (fr) 1974-01-18
CA1019745A (fr) 1977-10-25
AU5677273A (en) 1974-12-12
JPS5239815B2 (fr) 1977-10-07
ES415277A1 (es) 1976-02-01

Similar Documents

Publication Publication Date Title
FR2187327B1 (fr)
HU168131B (fr)
JPS4897529U (fr)
FR2189721B3 (fr)
JPS4879521A (fr)
JPS527558Y2 (fr)
JPS521521Y2 (fr)
JPS5530984B2 (fr)
JPS4987131A (fr)
JPS5333989Y2 (fr)
JPS5221710B2 (fr)
JPS493449U (fr)
JPS4952613A (fr)
CS158991B1 (fr)
CS155565B1 (fr)
JPS4955338A (fr)
JPS4894844U (fr)
JPS4955436A (fr)
JPS4999425U (fr)
CS158901B1 (fr)
CS159034B1 (fr)
JPS49104407U (fr)
CS154183B1 (fr)
CS156904B1 (fr)
CS156812B1 (fr)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse